The global pravastatin market is anticipated to grow at a considerable CAGR of 5.4% during the forecast period. Pravastatin is a drug called a statin, which is used to lower LDL (bad) cholesterol and triglycerides in the blood and increase HDL (good) cholesterol. The major factor expected to drive the market includes the rising demand for statins as an evidence-based treatment for patients suffering from lifestyle-related diseases, such as cardiovascular disorders, diabetes, and hypercholesterolemia. Furthermore, the increasing requirement for efficient drugs to diminish LDL cholesterol is also propelling market growth. Moreover, factors such as rising demand for over-the-counter (OTC) drugs and the growing adoption of combination therapies of statins with cholesterol-diminishing compounds are fueling the growth of the market during the forecast period.
Get Free Sample link @ https://www.omrglobal.com/request-sample/pravastatin-market
Moreover, the rising R&D activities in the pharmaceutical sector are also generating new opportunities for development in the market. For instance, the University of Camerino, Italy published a research article in April 2022 demonstrating the possibility to reformulate pravastatin tablets as a liquid pharmaceutical formulation for enteral administration to improve drug therapy in dysphagic patients.
A full report of Global Pravastatin Market available @ https://www.omrglobal.com/industry-reports/pravastatin-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Pravastatin Market by Dosage Type
- 10 mg Tablet
- 20 mg Tablet
- 40 mg Tablet
- 80 mg Tablet
Global Pravastatin Market by End User
- Children
- Adults
Regional Analysis
- North America
- US
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- Accord Healthcare, Ltd.
- Apotex, Inc.
- Aurobindo Pharma Ltd.
- Cipla, Inc.
- Daiichi Sankyo Co
- Jiangxi Boyaseehot Pharmaceutical Co., Ltd.
- Lupin Ltd.
- Mylan N.V.
- North China Pharmaceutical Group
- Shanghai Shyndec Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Upsher-Smith Laboratories, LLC
- Zhejiang Hisun Pharmaceutical Co., Ltd.
- Zydus Pharmaceuticals, Inc.?
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global pravastatin market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/pravastatin-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
